Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CLONICEL in Children and Adolescents with ADHD
NCT00723190Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by Shionogi & Co., Ltd.. Started Jan 2008; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00723190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723190.